<table class="drug-table data-table table table-condensed table-bordered">
  <tbody>
    <tr id="identification">
      <th class="divider" colspan="2">Identification</th>
    </tr>
    <tr>
      <th>Name</th>
      <td>
        <strong>Ergoloid mesylate</strong>
      </td>
    </tr>
    <tr>
      <th>Accession Number</th>
      <td><strong>DB01049</strong>&#160; (APRD00711, DB01287)</td>
    </tr>
    <tr>
      <th>Type</th>
      <td>small molecule</td>
    </tr>
    <tr>
      <th>Groups</th>
      <td>approved</td>
    </tr>
    <tr>
      <th>Description</th>
      <td>
        <p>Ergoloid mesylate is a dihydrogenated ergot (Claviceps purpurea) derivative alkaloid used as a vasodilator agent.  Ergoloid Mesylate is the only vasodilator that has shown mild benefits in the treatment of vascular dementia. Ergoloid Mesylate is a mixture of three different ergotamantriones: dihydroergocornine, dihydroergocristine, and dihydroergocryptine. It has been proposed to be a neuroprotective agent. The mechanism of its therapeutic actions is not clear.</p>
      </td>
    </tr>
    <tr>
      <th>Structure</th>
      <td>
        <div class="structure">
          <a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01049/image.png">
            <img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01049/thumb.png">
          </a>
        </div>
        <div class="structure-links">
          <div class="btn-group btn-group-xs">
            <a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01049.mol">MOL</a>
            <a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01049.sdf">SDF</a>
            <a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01049.pdb">PDB</a>
            <a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01049.smiles">SMILES</a>
            <a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01049.inchi">InChI</a>
            <a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01049">View Structure</a>
          </div>
        </div>
      </td>
    </tr>
    <tr>
      <th>Synonyms</th>
      <td class="data-table-container">
        <table class="table table-condensed table-striped datatable" id="synonyms">
          <thead>
            <th>Synonym</th>
            <th>Language</th>
            <th>Code</th>
          </thead>
          <tbody>
            <tr>
              <td>co-dergocrine mesilate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>co-dergocrine mesylate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>co-dergocrine methanesulfonate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>codergocrine mesilate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>codergocrine mesylate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>codergocrine methanesulfonate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Dihydroergotoxine Mesilate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Dihydroergotoxine Mesylate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>dihydroergotoxine methanesulfonate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Dihydroergotoxine Methanesulfonate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>dihydroergotoxine methanesulfonates</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>dihydroergotoxine monomethanesulfonate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>dihydrogenated ergot alkaloids</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Ergoloid Mesylates</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>USAN</td>
            </tr>
            <tr>
              <td>ergoloid methanesulfonate</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>ergoloid methanesulfonates</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>hydrogenated ergot alkaloids</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
          </tbody>
        </table>
      </td>
    </tr>
    <tr>
      <th>Salts</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Brand names</th>
      <td class="data-table-container">
        <table class="table table-condensed table-striped datatable" id="brands">
          <thead>
            <tr>
              <th>Name</th>
              <th>Company</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Alkergot</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Gerimal</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Hydergine</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
            <tr>
              <td>Hydergine LC</td>
              <td>
                <span class="wishart wishart-not-available">Not Available</span>
              </td>
            </tr>
          </tbody>
        </table>
      </td>
    </tr>
    <tr>
      <th>Brand mixtures</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Categories</th>
      <td>
        <ul><li><a href="/mesh/nootropic-agents">Nootropic Agents</a></li>
<li><a href="/mesh/vasodilator-agents">Vasodilator Agents</a></li>
<li><a href="/mesh/adrenergic-alpha-antagonists">Adrenergic alpha-Antagonists</a></li></ul>
      </td>
    </tr>
    <tr>
      <th>CAS number</th>
      <td>8067-24-1</td>
    </tr>
    <tr>
      <th>Weight</th>
      <td>Average: 631.74<br>Monoisotopic: 631.267584003</td>
    </tr>
    <tr>
      <th>Chemical Formula</th>
      <td>C<sub>30</sub>H<sub>41</sub>N<sub>5</sub>O<sub>8</sub>S</td>
    </tr>
    <tr>
      <th>InChI Key</th>
      <td>FQHMMOGHDWAXDI-WUQHHHCFSA-N</td>
    </tr>
    <tr>
      <th>InChI</th>
      <td>
        <div class="wrap">InChI=1S/C29H37N5O5.CH4O3S/c1-15(2)28(27(37)34-16(3)26(36)33-10-6-9-23(33)29(34,38)39-28)31-25(35)18-11-20-19-7-5-8-21-24(19)17(13-30-21)12-22(20)32(4)14-18;1-5(2,3)4/h5,7-8,13,15-16,18,20,22-23,30,38H,6,9-12,14H2,1-4H3,(H,31,35);1H3,(H,2,3,4)/t16-,18+,20+,22+,23-,28+,29-;/m0./s1</div>
      </td>
    </tr>
    <tr>
      <th>IUPAC Name</th>
      <td>
        <div class="wrap">(2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid</div>
      </td>
    </tr>
    <tr>
      <th>SMILES</th>
      <td>
        <div class="wrap">CS(O)(=O)=O.[H][C@@]12CCCN1C(=O)[C@H](C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C</div>
      </td>
    </tr>
    <tr>
      <th>Mass Spec</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr id="taxonomy">
      <th class="divider" colspan="2">Taxonomy</th>
    </tr>
    <tr>
      <th>Kingdom</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Superclass</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Class</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Subclass</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Direct parent</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Alternative parents</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Substituents</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Classification description</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr id="pharmacology">
      <th class="divider" colspan="2">Pharmacology</th>
    </tr>
    <tr>
      <th>Indication</th>
      <td>For use as an adjunct therapy for patients with dementia.</td>
    </tr>
    <tr>
      <th>Pharmacodynamics</th>
      <td>Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.</td>
    </tr>
    <tr>
      <th>Mechanism of action</th>
      <td>Ergoloid mesylates act centrally, decreasing vascular tone and slowing the heart rate, and acts peripherally to block alpha-receptors. One other possible mechanism is the effect of ergoloid mesylates on neuronal cell metabolism, resulting in improved oxygen uptake and cerebral metabolism, thereby normalizing depressed neurotransmitter levels.</td>
    </tr>
    <tr>
      <th>Absorption</th>
      <td>Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.</td>
    </tr>
    <tr>
      <th>Volume of distribution</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Protein binding</th>
      <td>98-99%</td>
    </tr>
    <tr>
      <th>Metabolism</th>
      <td class="data-table-container">
        <p>Hepatic.</p>
      </td>
    </tr>
    <tr>
      <th>Route of elimination</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Half life</th>
      <td>3.5 hours</td>
    </tr>
    <tr>
      <th>Clearance</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>Toxicity</th>
      <td>Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.</td>
    </tr>
    <tr>
      <th>Affected organisms</th>
      <td>
        <ul>
          <li>Humans and other mammals</li>
        </ul>
      </td>
    </tr>
    <tr>
      <th>Pathways</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>SNP Mediated Effects</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr>
      <th>SNP Mediated Adverse Drug Reactions</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    <tr id="admet">
      <th class="divider" colspan="2">ADMET</th>
    </tr>
    <tr>
      <th>Predicted ADMET features</th>
      <td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.8284</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9494</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.6447</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.6838</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.6581</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8001</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8838</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.75</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.7966</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.6681</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7702</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7072</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9221</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.6493</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7973</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8464</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.6324
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.6535
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9321
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.5438 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8821
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Inhibitor 
        </td>
        <td>
            0.5783
        </td>
      </tr>
  </tbody>
</table>
</td>
    </tr>
    <tr id="pharmacoeconomics">
      <th class="divider" colspan="2">Pharmacoeconomics</th>
    </tr>
    <tr>
      <th>Manufacturers</th>
      <td>
        <ul><li>Novartis pharmaceuticals corp</li>
<li>Mutual pharmaceutical co inc</li>
<li>Watson laboratories inc</li>
<li>Sandoz inc</li>
<li>3m pharmaceuticals inc</li>
<li>Bristol myers squibb co pharmaceutical research institute</li>
<li>Kv pharmaceutical co</li>
<li>Lederle laboratories div american cyanamid co</li>
<li>Superpharm corp</li>
<li>Vangard laboratories inc div midway medical co</li>
<li>Ivax pharmaceuticals inc</li></ul>
      </td>
    </tr>
    <tr>
      <th>Packagers</th>
      <td>
        <ul><li><a href="http://www.gallipot.com">Gallipot</a></li>
<li><a href="http://www.prescript.net">Prescript Pharmaceuticals</a></li></ul>
      </td>
    </tr>
    <tr>
      <th>Dosage forms</th>
      <td class="data-table-container">
        <table class="table table-condensed table-striped datatable" id="dosages">
          <thead>
            <tr>
              <th>Form</th>
              <th>Route</th>
              <th>Strength</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Tablet</td>
              <td>Oral</td>
              <td></td>
            </tr>
          </tbody>
        </table>
      </td>
    </tr>
    
    
    
    
    
    
    <tr id="spectra">
      <th class="divider" colspan="2">Spectra</th>
    </tr>
    <tr>
      <th>Spectra</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
    
    
    
    
    
    
    
    
    
    <tr id="interactions">
      <th class="divider" colspan="2">Interactions</th>
    </tr>
    <tr>
      <th>Drug Interactions</th>
      <td class="data-table-container">
        <table class="table table-condensed table-striped" id="experimental-properties">
          <thead>
            <tr>
              <th>Drug</th>
              <th style="width: 75%"></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                <a href="/drugs/DB06700">Desvenlafaxine</a>
              </td>
              <td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00976">Telithromycin</a>
              </td>
              <td>Telithromycin may reduce clearance of Ergoloid mesylates. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Ergoloid mesylates if Telithromycin is initiated, discontinued or dose changed.</td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00932">Tipranavir</a>
              </td>
              <td>Tipranavir may increase the plasma concentration of Ergoloid mesylates. Concomitant therapy should be avoided.</td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00193">Tramadol</a>
              </td>
              <td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00752">Tranylcypromine</a>
              </td>
              <td>Increased risk of serotonin syndrome. Use caution during concomitant therapy and monitor for symptoms of serotonin syndrome. </td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00656">Trazodone</a>
              </td>
              <td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00726">Trimipramine</a>
              </td>
              <td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome. </td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00285">Venlafaxine</a>
              </td>
              <td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00582">Voriconazole</a>
              </td>
              <td>Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of ergoloid mesylates by decreasing their metabolism. Concomitant therapy is contraindicated. </td>
            </tr>
            <tr>
              <td>
                <a href="/drugs/DB00315">Zolmitriptan</a>
              </td>
              <td>Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, ergoloid mesylate, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. </td>
            </tr>
          </tbody>
        </table>
      </td>
    </tr>
    <tr>
      <th>Food Interactions</th>
      <td>
        <span class="wishart wishart-not-available">Not Available</span>
      </td>
    </tr>
  </tbody>
</table>
